Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
Clinical trial NCT03097939 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03097939
- Sponsor
- National Cancer Centre, Singapore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-31
- Primary completion
- 2027-04-05
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.